Duvenhage, JanieKahts, MarykeSummers, BeverleyZeevaart, Jan RijnEbenhan, Thomas2024-11-212024-11Duvenhage, J., Kahts, M., Summers, B. et al. 2024, 'Highlighting new research trends on Zirconium-89 radiopharmaceuticals beyond antibodies', Seminars in Nuclear Medicine, vol. 54, no. 6, pp. 801-811, doi : 10.1053/j.semnuclmed.2024.10.003.1558-4623 (online)0001-2998 (print)10.1053/j.semnuclmed.2024.10.003http://hdl.handle.net/2263/99222Please read abstract in the article.en© 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Notice : this is the author’s version of a work that was accepted for publication in Seminars in Nuclear Medicine. Changes resulting from the publishing process, such as peer review, editing, corrections, structural formatting, and other quality control mechanisms may not be reflected in this document. A definitive version was subsequently published in Seminars in Nuclear Medicine, vol. 54, no. 6, pp. 801-811, doi : 10.1053/j.semnuclmed.2024.10.003.Zirconium-89Molecular imagingZirconium-89 radiopharmaceuticalsAntibodiesSDG-03: Good health and well-beingHighlighting new research trends on Zirconium-89 radiopharmaceuticals beyond antibodiesPostprint Article